Additional information
| Active substance | Survodutide |
|---|---|
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring blood glucose levels and HbA1c |
| Also known as | LY3298176 |
| Blood pressure | May reduce blood pressure |
| Trade name | Mounjaro |
| FORM | 1 vial x 10 mg |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F), protect from light |
| Chemical name | Tirzepatide |
| Formula | C225H348N48O68 |
| Substance class | Glucagon-like peptide-1 (GLP-1) receptor agonists |
| Main action | Lowers blood glucose levels |
| Half-life | Approximately 5 days |
| Dosage (medical) | Typically started at 2.5 mg once weekly, can be increased to 5 mg, 10 mg, or 15 mg once weekly depending on response and tolerability |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Effects | Improves glycemic control, promotes weight loss |
| Side effects | Nausea, diarrhea, decreased appetite, vomiting, constipation |
| Use in sports | None, not used for performance enhancement |
| Manufacturer | Dragon Pharma |
Alpha Pharma Rexogin 50 mg 10 Ampere
Balkan Pharma Strombaject 50mg 10 Ampullen
Avory Pharma Trenbolon-Depot 200 mg 10 ml
Avory Pharma Testosteron Cypionat 300 mg 10 ml
Thyromazol 5 mg Abdi Ibragim
Avory Pharma Deca Durabolin 300mg 10ml
Hardcore - xDrop Omega Lab
Alhavi Anapolon 50 mg 100 Tabletten
Balkan Pharma Propandrol 100 mg 10 Ampullen
Avory Pharma Sustanon 300mg 10ml
Thaiger Pharma Finexal 100 mg 10 ml
Euthyrox (T4) 150 mcg Merckgroup 

Reviews
There are no reviews yet.